Helix BioPharma Corp. (TSX:HBP)

Canada · Delayed Price · Currency is CAD

0.9000

0.00 (0.00%)

Nov 5, 2026, 2:41 PM EST

Helix BioPharma Financials Overview

Financials in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Jul '26 Jul 31, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022
Operating Income	-3.64	-3.64	-5.4	-9.24	-6.33	-6.04
Net Income	-3.35	-3.35	-5.21	-9.26	-6.29	-6.56
Earnings Per Share	-0.04	-0.04	-0.09	-0.21	-0.16	-0.22
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Jul '26 Jul 31, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022
Cash & Investments	0.8	0.8	0.07	1.08	0.81	3.25
Total Debt	4.16	4.16	0.34	-	-	2.47
Net Cash (Debt)	-3.35	-3.35	-0.27	1.08	0.81	0.78
Net Cash Growth	-	-	-	33.79%	3.06%	-
Net Cash Per Share	-0.04	-0.04	-0.00	0.02	0.02	0.03

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Jul '26 Jul 31, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022
Operating Cash Flow	-4.32	-4.32	-3.83	-5.22	-5.53	-6.51
Capital Expenditures	-	-	-0	-0.01	-0.01	-
Free Cash Flow	-4.32	-4.32	-3.83	-5.23	-5.54	-6.51
Free Cash Flow Growth	-	-	-	-	-	-

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 7, 2026	Jul '26 Jul 31, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022
Forward PE	-	10.00	10.00	10.00	10.00	10.00